Chardan Capital Has Weak Forecast for DYN FY2024 Earnings
Source: Etfdailynews
Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) – Stock analysts at Chardan Capital dropped their FY2024 earnings per share estimates for shares of Dyne Therapeutics in a research report issued on Wednesday, November 13th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($3.14) for the year, down […]